Nabriva Therapeutics

tell me more about the skin drug? Sounds exciting

 

It's for cUTIs

 

ugh!

 

ugh

 

Did anyone end up getting a job here? Looking to possibly transfer. I heard hospital stocking was successful at least. But you know, after that it sits on the shelf forever...if they get Contepo approved they will add that to sales force. Might be good for commissions.

 

This drug is a dog. There is no hospital stocking.

 

The landscape is littered with antibiotic start ups going bankrupt ..... sad but true

 

How’s the fat man Carpenter doing?

 

This one might be next to go bankrupt. Probably end of 2020 or beginning of 2021. So guess I won’t even look into a job. Confused as to why they would even be offering any of their drug is doing so poorly. Maybe for Contepo roll out.

 

I believe Tetraphase is next, then Paratek, then Nabriva. Melinta will be fine...another company will buy them.

 

Michael Kinkus will save Paratek.

 

With Paratek’s government cash infusion, I don’t think they will be out for a while. Nabriva seems to be burning fast. I just want a freaking job that lasts longer than a year. Why did I pick antibiotic sales?
Ahhhh! Let me know if you hear anything.

 

Anti biotic sales are the worst and the start ups stock prices are all around -$3 or less!!!

 

I don’t really care about the share price (as long as they are not bankrupt). I’m more in the job force.

 

Nabriva completely dropped the ball. They had two years to study the AB market for CAP and see what mistakes Achaogen and other AB companies to go bankrupt. Yet they still insisted to 'launch' straight into inpatient hospital market and the ED to add injury to insult. Launching their drug Xenleta through sheer ignorance and arrogance. Now six months later, more than half of the reps have not one sale nationwide, the others called in favors to customers to stock their drug, on the shelf mind you, not prescribed to patients. Mind you, most are seasoned reps that are good hospital reps.

The market access team (from Optimer and Otonomy) have completely dropped the ball. Now the knee jerk shift is to outpatient sales with little to no insurance coverage. They are selling MDs on commercial insurance coverage only with a 95% chance of a PA and access only through Walgreens Specialty Pharmacy through a faxed in patient application. They are practically forcing their reps to market Walgreens, because how else can they get a script filled without a $200 copay? Doctors and MAs are scoffing at this when they could just write a ZPAK for $4 and get it at any pharmacy.

The company is now desperate as their runway is Dec 2020 and running out. Managers are FLOGGING their reps, micromanaging, threatening, and nobody's happy. Rumor has it that most of the reps are looking elsewhere. This company is completely stupid and waiting to go bankrupt. They are putting all their hope in IV Fosfomycin for cUTI, if it is approved and if it takes off like wildfire within the first six months of it being potentially approved by the FDA. Market access dept is a complete joke. I would steer clear of this potential shipwreck. Anyone who doubts this opinion is probably a manager or home office drone who has drank the poisoned Kool Aid.

 

Paratek looks much better than the rest with their government contract for research. Melinta is dead. Who wants to buy drugs that do t make money?

 

Ugh? And who is buying our drug?? Paratek, Nabriva drugs are dogs. Only hope contepo

 

not a rumor at all.
I’ve had reps contacting me for a job. All makes sense now.

I’m not a shareholder, but why and how does the CEO still have a job?

 

Sorry guys! I’ve been there, I understand. Good luck to all

 

Can’t believe no one has posted of how nabriva fired its entire sales force yesterday. Look at sec filing where they say they are going to hire a brand new community sales force. Completely and totally unethical and unfeeling. They cannot say they care about patients if they don’t give a hoot about their employees. As a small business they could have taken the forgivable loan from the feds and kept their employees working during these unprecedented times.
Terrible terrible company and top leadership. Shame on them.